NSE மற்றும் BSE-யின் ஒவ்வொரு கார்ப்பரேட் அறிவிப்பும், AI-யால் சில நிமிடங்களில் படிக்கப்பட்டு விளக்கப்படுகிறது — தாக்கம், முக்கிய புள்ளிவிவரங்கள், குறுகிய/நீண்டகாலப் பார்வை, கவனிக்க வேண்டியவை.
நேரலைசமீபத்திய அறிவிப்பு: 16 மணி நேரத்திற்கு முன்இன்று 99 பகுப்பாய்வு செய்யப்பட்டது
குறிப்பு: இவை NSE பொது அறிக்கைகளின் AI-உருவாக்கிய, கல்வி நோக்கச் சுருக்கங்கள் — ஒவ்வொரு ஆவணத்தையும் ஆதாரமாகக் கொண்டவை, ஆனால் முதலீட்டு ஆலோசனை அல்ல, மேலும் முழுமையற்றதாகவும் இருக்கலாம். அசல் அறிக்கையுடன் சரிபார்க்கவும், செயல்படுவதற்கு முன் SEBI-பதிவு பெற்ற முதலீட்டு ஆலோசகரை அணுகவும்.
UFLEX Q2 Normalized EBITDA Rises 94.8% YoY to ₹758.8 Cr with 15.6% Margin
UFLEX reported its financial results for the quarter ended September 30, 2026. Consolidated Normalized EBITDA surged 94.8% YoY to ₹758.8 crore (Rs 7,588 million) compared to ₹389.5 crore (Rs 3,895 million) in Q2 FY26, with normalized EBITDA margins expanding to 15.6%. Operating cash flows for H1 FY27 reached ₹1,085.0 crore, up sharply from ₹379.4 crore in H1 FY26. For its US subsidiary Flex Films (USA) Inc., total revenue stood at ₹629.77 crore with a net loss after tax of ₹9.17 crore for the quarter.
உச்சம் நம்பிக்கை
என்ன மாறியதுUFLEX posted its Q2 and H1 FY27 financial performance showing a near doubling of normalized EBITDA and strong operating cash flows.
ஏன் இது முக்கியம்Higher normalized EBITDA margin (15.6%) and strong operating cash generation improve debt-servicing capabilities on its existing ₹4,268 crore debt load.
📅 குறுகிய காலம்Operating performance recovery and margin expansion are likely to be viewed positively following historical margin volatility.
📈 நீண்ட காலம்Structural improvement depends on continuing recovery in global packaging film spreads and sustained utilization across international facilities.
⚠ அபாய எச்சரிக்கைகள்
Flex Films (USA) Inc. continues to post a quarterly net loss of Rs 917 Lacs
High short-term borrowings of Rs 41,100 million
Sensitivity to crude-linked raw material price volatility and packaging film overcapacity
👀 கவனிக்க வேண்டியவை
Track capacity ramp-up and pricing trends across overseas plants, and monitor sustained cash generation against total borrowings.
UFLEX Secures Shareholder Approval to Borrow Up to ₹5,000 Crore with 99.92% Majority
UFLEX Limited announced the outcome of its postal ballot, where shareholders approved increasing the company's borrowing limit under Section 180(1)(c) of the Companies Act up to ₹5,000 crore. The special resolution passed with an overwhelming majority of 99.92% of the 3,33,02,197 total valid votes cast. This borrowing limit represents approximately 117% of the company's current total debt of ₹4,268 crore and roughly 121% of its market capitalization (₹4,118 crore). The remote e-voting took place between October 2, 2026, and October 31, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுShareholders officially passed a special resolution empowering the Board to borrow up to ₹5,000 crore.
ஏன் இது முக்கியம்Enables UFLEX to raise additional debt funding to support ongoing capex (such as PET chips expansion) or working capital needs without needing further approvals.
📅 குறுகிய காலம்Neutral procedural milestone. The approval is an enabling resolution; actual market reaction will depend on when and how debt is drawn down.
📈 நீண்ட காலம்Provides headroom to fund capital projects like overseas and domestic expansions, though substantial additional debt on a D/E of 1.26 could increase interest costs.
⚠ அபாய எச்சரிக்கைகள்
High existing leverage (debt of ₹4,268 cr with D/E of 1.26) may strain balance sheet if borrowing limit is heavily utilized
Commoditized pricing pressure in packaging films could compress cash flows needed for debt servicing
👀 கவனிக்க வேண்டியவை
Track the company's upcoming quarterly filings for any actual debt issuances or term loan drawdowns, and monitor leverage metrics against its current debt-to-equity ratio of 1.26.
CRISIL Reaffirms UFLEX's Rs 4,600 Cr Bank Facilities at 'AA-/Negative' and 'A1+'
CRISIL Ratings has reaffirmed its ratings for UFLEX Limited's bank loan facilities totaling Rs 4,600 crore. The long-term rating is maintained at 'CRISIL AA-' with a 'Negative' outlook, while the short-term rating is reaffirmed at 'CRISIL A1+'. The Rs 4,600 crore facility closely aligns with UFLEX's total debt load of Rs 4,268 crore (D/E of 1.26). The negative outlook reflects ongoing monitoring by the agency regarding debt levels and operating performance in the packaging films segment.
உச்சம் நம்பிக்கை
என்ன மாறியதுCRISIL reaffirmed UFLEX's credit ratings at AA-/Negative (long term) and A1+ (short term) across its Rs 4,600 crore bank loan facilities.
ஏன் இது முக்கியம்Maintains banking access and debt terms across the company's Rs 4,600 crore borrowing lines, though the 'Negative' outlook signals continued credit scrutiny over leverage.
Total bank loan facilities rated: Rs.4600 CroreLong-term rating: Crisil AA-/NegativeShort-term rating: Crisil A1+Rated facilities vs Total Debt: ~107.8%
📅 குறுகிய காலம்Neutral market impact since ratings are unchanged; however, the persistent Negative outlook serves as a reminder of high leverage risk.
📈 நீண்ட காலம்If operating performance stays pressured by global packaging film oversupply, the negative outlook could translate into a downgrade, raising borrowing costs on UFLEX's Rs 4,268 crore debt pile.
⚠ அபாய எச்சரிக்கைகள்
Negative outlook on long-term rating indicates risk of a rating downgrade
Elevated leverage with D/E at 1.26 and total debt of Rs 4,268 crore
👀 கவனிக்க வேண்டியவை
Track whether upcoming quarterly margins and cash flow generation support deleveraging to prevent a potential downgrade from the current 'Negative' outlook.
UFLEX Seeks Shareholder Approval to Hike Borrowing Limit by ₹1,000 Cr to ₹5,000 Cr
UFLEX Limited has issued a Postal Ballot notice seeking shareholder approval to increase its borrowing limit from ₹4,000 Crore to ₹5,000 Crore under Section 180(1)(c) of the Companies Act, 2013. The company stated that existing borrowing limits are nearing full utilization and the additional headroom is needed to fund its ongoing 54,000 MTPA BOPP film expansion at Dharwad, Karnataka, expected to commission in FY28. Debt drawdown is scheduled during FY27. Remote e-voting results are scheduled to be announced on or before November 2, 2026.
உச்சம் நம்பிக்கை
என்ன மாறியதுUFLEX is seeking shareholder authorization to expand its borrowing capacity by ₹1,000 Crore (a 25% increase over previous limits).
ஏன் இது முக்கியம்Enables the company to legally draw down additional debt during FY27 to execute the Dharwad BOPP plant expansion without breaching statutory limits.
📅 குறுகிய காலம்Neutral procedural matter; postal ballot results on November 2, 2026, are likely to pass smoothly given the board's recommendation.
📈 நீண்ட காலம்Increases balance sheet leverage potential; with current debt at ₹4,268 Cr and D/E at 1.26, incremental borrowing will need to be matched by timely project execution and cash flow delivery to prevent balance sheet strain.
⚠ அபாய எச்சரிக்கைகள்
Higher leverage risk as existing limits are nearing exhaustion and D/E is already at 1.26
Execution/delay risks for the Dharwad facility through FY28
👀 கவனிக்க வேண்டியவை
Track the outcome of the postal ballot voting on November 2, 2026, and monitor leverage ratios as debt drawdowns begin in FY27.
UFLEX Q1 FY27 Transcript: PAT Surges to ₹423.3 Cr on 38% Revenue Growth to ₹5,397.2 Cr
UFLEX reported robust Q1 FY27 performance with consolidated revenue increasing 38% YoY to ₹5,397.2 crore, propelled by international operations. Consolidated EBITDA surged 92% YoY to ₹919.8 crore with margins expanding 480 bps to 17.0%, while PAT rose to ₹423.3 crore from ₹58.0 crore in Q1 FY26. Overseas operations contributed ~91% of incremental EBITDA, benefiting from strong local sourcing demand and localized supply chain de-risking amid regional disruptions. The company incurred ₹478.2 crore in capex during the quarter, with key commissioning milestones achieved in Noida and Mexico.
உச்சம் நம்பிக்கை
என்ன மாறியதுUFLEX released the transcript of its Q1 FY27 earnings conference call detailing operational performance, regional volume trends, and capex execution.
ஏன் இது முக்கியம்Demonstrates strong operational leverage and localized pricing power across overseas plants (Egypt, Mexico, Nigeria), driving multi-quarter high EBITDA margins of 17%.
📅 குறுகிய காலம்Management guided for some normalization in Q2 realizations after exceptionally high Q1 spreads, though underlying volumes and margins remain healthy.
📈 நீண்ட காலம்The company's 'Glocal' manufacturing strategy is successfully mitigating global freight disruptions and capturing regional premiums across the Americas, Africa, and the Middle East.
⚠ அபாய எச்சரிக்கைகள்
Commodity cyclicality and oversupply risks in global packaging film markets.
Vulnerability to raw material cost spikes linked to crude prices.
👀 கவனிக்க வேண்டியவை
Track the ramp-up of newly commissioned Noida recycling and Mexico WPP units, along with progress on the 12-billion-pack Egypt aseptic plant targeted for FY27 commissioning.
📊 கடந்த 7 நாட்கள் — உணர்வு அடிப்படையில் பகுப்பாய்வு செய்யப்பட்ட அறிவிப்புகள்
UFLEX Q1 FY27 Revenue Jumps 37.6% YoY to ₹5,397.2 Cr; EBITDA Rises 92.1% to ₹919.8 Cr
UFLEX reported strong performance in Q1 FY27 with consolidated revenue rising 37.6% YoY to ₹53,972 million (₹5,397.2 crore) and EBITDA advancing 92.1% YoY to ₹9,198 million (₹919.8 crore). EBITDA margins expanded by 480 bps YoY to 17.0%, driven by operating leverage, higher packaging film realizations, and localized sourcing premiums in overseas subsidiaries. Consolidated PAT reached ₹4,233 million (₹423.3 crore) with a margin of 7.8%. Additionally, the company commissioned a 39,600 MTPA recycling unit in Noida and an 80-million-unit WPP bags facility in Mexico.
உச்சம் நம்பிக்கை
என்ன மாறியதுUFLEX published its Q1 FY27 earnings presentation, highlighting sharp margin expansion and the operationalization of new recycling and packaging capacities in India and Mexico.
ஏன் இது முக்கியம்Demonstrates operating leverage and pricing resilience amid geopolitical and supply chain disruptions, reinforcing profitability through value-added products and international manufacturing hubs.
📅 குறுகிய காலம்Positive sentiment likely following the 21-quarter high EBITDA margin of 17%, although management flagged potential normalization in realizations during Q2 FY27.
📈 நீண்ட காலம்Expansion into recycling (PCR chips), aseptic liquid packaging, and localized production in the Americas and MEA supports structural volume growth and reduces global supply chain risks.
⚠ அபாய எச்சரிக்கைகள்
Vulnerability to raw material cost spikes (crude-linked feedstocks like MEG and Homo Polypropylene)
Freight and supply chain disruptions stemming from the West Asia conflict
Pricing normalization in packaging films over coming quarters
👀 கவனிக்க வேண்டியவை
Track management commentary in the earnings call regarding sustainability of elevated realizations, the ramp-up of the Noida recycling and Mexico WPP facilities, and the commissioning timeline of the Egypt aseptic packaging project.
UFLEX Q1 FY27 Net Profit Surges 630% YoY to Rs 4,233 Mn; EBITDA Margin Reaches 17.0%
UFLEX reported a strong operational performance in Q1 FY27, with consolidated revenue rising 37.6% YoY to Rs 53,972 Mn and net profit surging 629.6% YoY to Rs 4,233 Mn. EBITDA increased 92.1% YoY to Rs 9,198 Mn, driving EBITDA margins up by 480 bps YoY to 17.0% (the highest in 21 quarters), aided by better product spreads, operating leverage, and a Rs 825 Mn forex gain. Total sales volume rose 1.7% YoY to 173,471 MT, with overseas revenue contribution increasing to 62% from 56% in Q1 FY26. Growth was underpinned by backward integration at its Panipat PET chips facility and newly commissioned units in Noida and Mexico.
உச்சம் நம்பிக்கை
என்ன மாறியதுUFLEX posted a sharp operational turnaround in Q1 FY27 with a 6.3x YoY net profit surge driven by improved film realizations and operating leverage.
ஏன் இது முக்கியம்Higher product spreads and benefits from captive backward integration (Panipat virgin PET chips) significantly improved profitability, achieving multi-quarter-high EBITDA margins.
Total Income (Q1 FY27): Rs. 53,972 MnConsolidated Net Profit: Rs. 4,233 MnConsolidated EBITDA: Rs. 9,198 MnEBITDA லாப வரம்பு: 17.0%Sales Volume: 173,471 MTForex Gain in EBITDA: Rs. 825 Mn
📅 குறுகிய காலம்Strong quarterly performance is expected to support near-term sentiment, although Q2 FY27 may see slight sequential margin moderation due to seasonal trends.
📈 நீண்ட காலம்Backward integration in PET chips and global manufacturing expansions across Mexico, Egypt, and India structurally enhance supply security and margin defense against global supply chain volatility.
⚠ அபாய எச்சரிக்கைகள்
Cyclicality in flexible packaging film spreads and pricing power limits
Volatile crude-linked raw material prices (PTA, MEG) and supply bottlenecks
Domestic margin pressure in aseptic packaging due to aggressive imports
👀 கவனிக்க வேண்டியவை
Monitor packaging film realization sustainability in Q2 FY27 following management's note on potential seasonal normalization, along with commissioning timelines for the upcoming Egypt aseptic packaging plant.
UFLEX reported its Q1 financial results for the quarter ended June 30, 2026, with standalone revenue from operations reaching ₹2,344.25 Cr compared to ₹2,058.01 Cr in the prior-year period. Standalone profit before tax stood at ₹84.09 Cr versus ₹77.46 Cr in Q1 FY26. Operationally, the company commissioned a PET bottles and mixed plastics recycling facility at Noida during the quarter. Separately, the statutory auditor highlighted an ongoing Income Tax demand of ₹500.68 Cr (for AY 2020-21 to 2023-24) stemming from a February 2023 search, which is currently pending adjudication before the ITAT.
உச்சம் நம்பிக்கை
என்ன மாறியதுUFLEX declared its Q1 quarterly financial results and announced the successful commissioning of a recycling unit at Noida.
ஏன் இது முக்கியம்Shows operational stability in standalone operations while highlighting contingent exposure to tax litigation equal to ~14.8% of net worth.
Standalone Revenue (Q1): ₹2,344.25 கோடிStandalone PBT (Q1): ₹84.09 கோடிContested Tax Demand: ₹500.68 கோடிTax Demand vs Net Worth: ~14.8%Foreign Subsidiaries Revenue: ₹3,032.11 கோடி
📅 குறுகிய காலம்Stock is likely to react neutrally to the steady operational numbers as the tax dispute remains an ongoing matter already known to markets.
📈 நீண்ட காலம்Value addition through circular economy initiatives (recycling) and overseas capacity utilization remain central to long-term profitability amidst packaging film commoditization.
⚠ அபாய எச்சரிக்கைகள்
Pending tax demand of ₹500.68 Cr under ITAT cross-appeals
Elevated leverage with D/E ratio at 1.26 (Debt: ₹4,268 Cr)
Commodity pricing risks and overcapacity in flexible packaging films
👀 கவனிக்க வேண்டியவை
Track the upcoming full consolidated margin performance and monitor legal updates regarding the ITAT proceedings on the ₹500.68 Cr tax demand.
CRISIL Reaffirms AA- Rating for Rs 4,600 Cr Facilities; Outlook Revised to Negative
CRISIL has reaffirmed UFLEX's long-term credit rating at 'CRISIL AA-' but has revised the outlook from 'Stable' to 'Negative'. This rating applies to bank loan facilities totaling Rs 4,600 crore, which is significant as it exceeds the company's current market capitalization of Rs 3,656 crore. The short-term rating remains unchanged at 'CRISIL A1+'. The negative outlook indicates potential pressure on the company's credit profile, likely stemming from its high debt levels of Rs 4,268 crore and a debt-to-equity ratio of 1.26.
உச்சம் நம்பிக்கை
என்ன மாறியதுThe credit rating outlook for UFLEX's long-term debt has been downgraded from 'Stable' to 'Negative', while the underlying rating of 'AA-' was maintained.
ஏன் இது முக்கியம்A negative outlook is a warning signal that borrowing costs could increase if a formal downgrade occurs. For a company with Rs 4,268 crore in debt, higher interest expenses could significantly impact the net profit margin, which stood at a modest 12.1% (OPM) TTM.
Total Rated Facilities: Rs 4,600 கோடிRated Facilities vs Market Cap: 125.8%Total Debt: Rs 4,268 கோடிDebt-to-Equity Ratio: 1.26TTM வருவாய்: Rs 15,401 கோடி
📅 குறுகிய காலம்The revision to a negative outlook may lead to short-term price volatility as it signals increased credit risk and potential future pressure on the balance sheet.
📈 நீண்ட காலம்The company's ability to service its high debt while navigating overcapacity in the packaging film industry remains a structural concern over the next several quarters.
⚠ அபாய எச்சரிக்கைகள்
High leverage (D/E 1.26)
Negative credit outlook
Commoditized industry with limited pricing power
Exposure to raw material price volatility
👀 கவனிக்க வேண்டியவை
Investors should monitor the specific triggers in the CRISIL rationale that could lead to a formal rating downgrade, particularly margin pressure or delays in capacity utilization at the new Panipat plant. Watch for debt reduction progress in upcoming quarterly results to see if the 'Negative' outlook is stabilized.
80 Million Bags/Year: UFLEX Commences Commercial Production at Mexico Facility
UFLEX Limited has successfully commenced commercial production at its new manufacturing facility in Mexico through its wholly-owned subsidiary, Uflex Woven Bags, S.A. de C.V. The facility, which started operations on July 31, 2026, has an installed capacity of 80 million bags per annum. This expansion is part of the company's 'Glocal' strategy to serve the North American market, potentially benefiting from USMCA trade terms. The project was completed approximately 17 months after its initial announcement in February 2025.
உச்சம் நம்பிக்கை
என்ன மாறியதுUFLEX has transitioned its new Mexico-based woven bag manufacturing unit from the construction phase to active commercial production.
ஏன் இது முக்கியம்This expansion enhances UFLEX's ability to serve the U.S. and North American markets directly, reducing lead times and potentially mitigating trade-related risks while utilizing its global manufacturing strategy.
📅 குறுகிய காலம்The announcement is likely to be viewed positively by the market as it demonstrates timely execution of the expansion plan announced in early 2025.
📈 நீண்ட காலம்Structurally positive as it strengthens the company's presence in the Americas and provides a hedge against regional supply chain disruptions, contributing to the targeted 10-12% growth rate.
⚠ அபாய எச்சரிக்கைகள்
Ramp-up risk in achieving full capacity utilization
Exposure to raw material price volatility
Geopolitical risks affecting trade in the North American region
👀 கவனிக்க வேண்டியவை
Investors should monitor the capacity utilization rates of the new Mexico facility in the next 2-3 quarters to gauge its contribution to the top line. Additionally, watch for improvements in operating margins as the company leverages localized production for the U.S. market.
UFLEX Appoints Arun Kumar Sharma as CFO; Brings 35+ Years of Experience
UFLEX Limited has appointed Mr. Arun Kumar Sharma as its Chief Financial Officer (CFO) and Key Managerial Personnel, effective July 10, 2026. Mr. Sharma is a Chartered Accountant with over 35 years of experience, including a previous leadership stint at Jubilant Group as CFO and Head of Group Treasury. This leadership change is significant as the company manages a substantial TTM revenue of Rs 15,401 crore and a high debt-to-equity ratio of 1.26. His background in treasury management will be critical for UFLEX's capital-intensive operations and debt servicing requirements.
உச்சம் நம்பிக்கை
என்ன மாறியதுUFLEX has appointed a new Chief Financial Officer, Mr. Arun Kumar Sharma, to lead its financial and treasury functions.
ஏன் இது முக்கியம்For a company with Rs 15,401 crore in TTM revenue and significant leverage, a seasoned CFO with treasury experience is vital for maintaining financial stability and managing global cash flows.
Professional Experience: 35+ yearsEffective Date: ஜூலை 10, 2026TTM வருவாய்: Rs 15,401 கோடிTotal Debt: Rs 4,268 கோடிDebt/Equity Ratio: 1.26
📅 குறுகிய காலம்The appointment is expected to have a neutral impact on the stock price in the short term as it is a standard leadership transition.
📈 நீண்ட காலம்A seasoned CFO with treasury expertise could potentially optimize the company's debt structure and improve financial reporting transparency over the coming years.
👀 கவனிக்க வேண்டியவை
Watch for any shifts in the company's debt management strategy or capital allocation plans under the new CFO's leadership, particularly regarding the high 1.26 D/E ratio.
UFLEX Targets 24 Billion Aseptic Pack Capacity by FY2027; FY26 Revenue at Rs 15,513 Cr
UFLEX reported FY26 consolidated revenue of Rs 15,513 Cr with an EBITDA of Rs 1,983.6 Cr. The company is aggressively expanding its high-margin aseptic packaging business, aiming to double capacity from 12 billion to 24 billion packs per annum by FY2027. Key operational milestones include the commissioning of a 1,68,000 MTPA PET chips plant in Panipat and a 5 billion pack expansion in Sanand. Future growth is anchored by a new aseptic plant in Egypt and a 54,000 MTPA BOPP line in Dharwad.
உச்சம் நம்பிக்கை
என்ன மாறியதுUFLEX has provided a clear roadmap for doubling its aseptic packaging capacity by FY2027 and confirmed the successful commissioning of the Panipat PET chips facility.
ஏன் இது முக்கியம்The shift toward value-added aseptic packaging and backward integration into PET chips is intended to improve margins and reduce reliance on commoditized packaging films, which face oversupply risks.
📅 குறுகிய காலம்The market may react positively to the recovery in BOPET and BOPP pricing trends noted in Q4 FY26 and the clear growth targets for FY27.
📈 நீண்ட காலம்Structural shift towards value-added aseptic packaging and recycling (Project Plastic Fix) could re-rate the business if execution meets the 24 billion pack target by FY2027.
⚠ அபாய எச்சரிக்கைகள்
High debt levels (Rs 4,268 Cr)
Raw material price sensitivity (crude-linked PTA/MEG)
Global supply chain disruptions impacting freight costs
👀 கவனிக்க வேண்டியவை
Monitor the commissioning timeline of the Egypt aseptic plant and the Dharwad BOPP line, as these are key to margin improvement. Watch for the impact of raw material price volatility (PTA/MEG) on operating margins given the company's high debt levels.
UFLEX Recommends Rs 3 Dividend for FY 2025-26; Sets Record Date for June 26
UFLEX Limited has recommended a dividend of Rs 3 per equity share (30% of face value) for the financial year ended March 31, 2026. The company has fixed June 26, 2026, as the record date to determine shareholder eligibility for the payout. The dividend is subject to approval at the upcoming Annual General Meeting on July 29, 2026, and will be paid by August 27, 2026. Shareholders are required to submit tax-related documentation by the record date to ensure appropriate TDS rates are applied.
முக்கிய அம்சங்கள்
Dividend of Rs 3 per equity share (30% of face value) recommended for FY 2025-26Record date for dividend eligibility set for June 26, 2026TDS of 10% applicable for resident shareholders with PAN; 20% for those without valid PAN or Aadhaar linkingExemption from TDS for individual shareholders if the total dividend amount does not exceed Rs 10,000Dividend payment to be processed on or before August 27, 2026, following AGM approval
👀 கவனிக்க வேண்டியவை
Shareholders should ensure their PAN is updated and linked to Aadhaar, and submit necessary tax exemption forms by June 26, 2026, to avoid higher tax deductions.
UFlex Reports Strong Q4FY26: EBITDA Jumps 36.3% QoQ to Rs 6,265 Million
UFlex delivered a robust Q4FY26 performance with consolidated revenue reaching Rs 40,973 million, a 12.8% sequential increase. Profitability saw a significant boost as EBITDA margins expanded to 15.3%, the highest in 14 quarters, driven by improved realizations and a better product mix. The company's international business now contributes 57% of total revenue, supported by a 23% sequential volume growth in the Americas. Management remains optimistic for FY27, expecting growth from new capacities in Egypt, Mexico, and India.
முக்கிய அம்சங்கள்
Q4 EBITDA surged 36.3% QoQ and 31.8% YoY to Rs 6,265 million, with margins expanding to 15.3%.Consolidated sales volume for Q4 increased 10.3% sequentially to 166,879 MT.Aseptic packaging business recorded 7.97 billion packs for FY26, showing resilience despite seasonal disruptions.Americas region led volume growth with a 23% sequential increase, while international revenue share rose to 57%.FY26 consolidated revenue stood at Rs 155,130 million with a 70 bps expansion in EBITDA margin to 12.8%.
👀 கவனிக்க வேண்டியவை
Investors should maintain a positive outlook as the company achieves multi-quarter high margins and successfully ramps up international volumes. Key monitors include the utilization levels of the new Dharwad BOPP line and the Egypt aseptic facility in FY27.
UFLEX Q4 FY26 Revenue Rises 5.7% YoY to Rs 40,973 Mn; EBITDA Margins Expand to 15.3%
UFLEX reported a strong Q4 FY26 with revenue reaching Rs 40,973 million, driven by a 10.3% sequential volume growth. EBITDA margins saw a significant expansion of 300 bps YoY to 15.3%, aided by improved product mix and inventory optimization. The company is aggressively expanding its global footprint with major capex projects in Egypt and Mexico, alongside a capacity hike in its Sanand aseptic packaging facility from 7 billion to 12 billion packs per annum. Despite domestic FMCG moderation, the company benefited from improved realizations in the packaging films segment due to global supply chain disruptions.
முக்கிய அம்சங்கள்
Q4 FY26 Revenue grew 12.8% QoQ to Rs 40,973 Mn, while FY26 revenue reached Rs 155,130 Mn.EBITDA for Q4 jumped 31.8% YoY to Rs 6,265 Mn, with margins expanding to 15.3% from 12.3% YoY.Aseptic packaging capacity at Sanand increased from 7 billion to 12 billion packs per annum during FY26.Total Q4 sales volumes rose 10.3% QoQ to 166,879 MT, led by growth in both Packaging Films and Packaging segments.Significant capex of Rs 7,070 Mn incurred in Q4 for major projects in Egypt (Aseptic), Mexico (WPP), and India (Recycling and BOPP).
👀 கவனிக்க வேண்டியவை
Investors should monitor the commissioning of the Egypt and Mexico plants in H1 FY27, which are expected to drive the next phase of volume growth. The sharp recovery in EBITDA margins is a positive signal, though geopolitical risks affecting raw material supply chains remain a factor to watch.
UFLEX Q4 FY26 EBITDA Jumps 31.8% YoY to Rs 6,265 Mn; Margins Expand to 15.3%
UFLEX Limited reported a strong performance for Q4 FY26, with consolidated revenue growing 5.7% YoY to Rs 40,973 Mn. The company achieved significant margin expansion, with EBITDA margins rising 300 bps YoY to 15.3%, driven by improved realizations and operational excellence despite geopolitical headwinds. Normalized PAT for the quarter surged 105.5% YoY to Rs 2,026 Mn. For the full fiscal year 2026, revenue reached Rs 155,130 Mn with a normalized PAT of Rs 3,362 Mn, up 5% YoY.
முக்கிய அம்சங்கள்
Q4 FY26 EBITDA increased 31.8% YoY to Rs 6,265 Mn, with margins expanding by 300 bps to 15.3%.Normalized PAT for Q4 FY26 grew by 105.5% YoY to Rs 2,026 Mn, showing a sharp recovery from previous quarters.Sales volume for the quarter stood at 166,879 MT, representing a 10.3% sequential (QoQ) growth.Aseptic Liquid Packaging sales volumes grew 15.9% QoQ to 2.08 billion packs in Q4 FY26.New capacities including a 12 billion pack aseptic facility in Egypt and a 36,000 MTPA rPET plant in Noida are on track for commissioning.
👀 கவனிக்க வேண்டியவை
Investors should take note of the significant margin recovery and the company's ability to navigate supply chain disruptions in the packaging film segment. The upcoming commissioning of large-scale international capacities in Egypt and Mexico suggests a positive outlook for volume-led growth in FY27.
UFLEX Limited has approved its audited financial results for the fiscal year ended March 31, 2026, receiving an unmodified audit opinion. The Board has recommended a dividend of ₹3 per equity share (30% of face value), with a record date of June 26, 2026. Additionally, the company has approved the re-appointment of Mr. Paresh Nath Sharma as an Independent Director for a second five-year term starting February 2027. Investors should note an 'Emphasis of Matter' regarding ongoing income tax litigation and search proceedings from 2023, which are currently pending adjudication.
முக்கிய அம்சங்கள்
Recommended a dividend of ₹3 per equity share (30%) for the financial year ended March 31, 2026.Approved audited standalone and consolidated financial results for FY26 with an unmodified audit opinion.Re-appointed Mr. Paresh Nath Sharma as Independent Director for a second 5-year term (2027-2032).Set the record date for dividend and AGM as June 26, 2026, with payment by August 27, 2026.Disclosed ongoing income tax disputes for AY 2020-21 to 2022-23 currently pending before the ITAT.
👀 கவனிக்க வேண்டியவை
Investors should note the record date of June 26, 2026, to be eligible for the ₹3 dividend and monitor the legal developments regarding the pending income tax assessments mentioned in the audit report.
UFLEX Recommends ₹3 Dividend; Sets June 26, 2026, as Record Date
UFLEX Limited has recommended a dividend of ₹3 per equity share (30% of face value) for the financial year ended March 31, 2026. The company has fixed June 26, 2026, as the record date to determine eligibility for the dividend payment. The dividend is subject to shareholder approval at the upcoming Annual General Meeting scheduled for July 29, 2026. Additionally, the company reported audited financial results for FY26 and noted ongoing tax litigation regarding search proceedings from 2023.
முக்கிய அம்சங்கள்
Recommended a dividend of ₹3 per equity share of ₹10 each (30%) for FY 2025-26.Fixed June 26, 2026, as the Record Date for the purpose of dividend payment.Dividend payment will be completed on or before August 27, 2026, if approved by shareholders.Book closure period set from June 27, 2026, to July 3, 2026.Reported ongoing income tax appeals for AY 2020-21 to 2022-23 currently pending before the ITAT.
👀 கவனிக்க வேண்டியவை
Investors interested in the dividend should ensure they hold shares before the ex-dividend date, which typically precedes the June 26 record date. Long-term investors should also monitor the resolution of the pending income tax litigation mentioned in the auditor's report.
UFLEX Commissions 39,600 MTA Recycling Unit for PET Bottles and Mixed Plastics in Noida
UFLEX Limited has successfully commissioned its new recycling facility in Noida as of April 30, 2026. The unit is designed to process PET bottles and mixed plastics with a significant capacity of 39,600 MTA. This project, initially announced in February 2025, strengthens the company's commitment to the circular economy and sustainable packaging. The commissioning marks a key milestone in the company's operational expansion and ESG initiatives.
முக்கிய அம்சங்கள்
Successfully commissioned the recycling unit in Noida on April 30, 2026Total processing capacity of the new unit stands at 39,600 MTAFacility is equipped to handle both PET bottles and mixed plastic wasteProject completion follows the initial announcement made on February 14, 2025
👀 கவனிக்க வேண்டியவை
Investors should view this as a positive development that enhances UFLEX's ESG profile and operational capacity. Monitor the impact of this facility on the company's green product portfolio and overall margins in the coming quarters.
UFLEX Targets 24 Billion Aseptic Pack Capacity by FY26; Plans Major Global Expansions
UFLEX Limited is aggressively scaling its high-margin aseptic liquid packaging business, aiming to double its capacity to 24 billion packs per year by FY2026. The company is set to commission a new 12 billion pack plant in Egypt and an 80 million capacity WPP bag facility in Mexico during 2026. With a global manufacturing capacity of over 1.35 million MTPA, UFLEX is well-positioned to capitalize on India's packaging market, which is projected to grow at a 10.2% CAGR through 2027. Recent trends show a broad-based decline in raw material costs like PTA and MEG, which may support margin recovery.
முக்கிய அம்சங்கள்
Aiming to reach 24 billion aseptic carton packs per year capacity by FY2026 from the current 12 billion.Total global manufacturing capacity stands at 1,351,910 MTPA across 17 units and 150+ countries.Commissioning a 12 billion pack aseptic plant in Egypt and an 80 million WPP bag facility in Mexico in 2026.Setting up two new recycling plants in Noida for PCR PET and PCR MLP to enhance sustainability profile.India's packaging market is forecasted to grow from $102 billion in 2023 to $150 billion by 2027.
👀 கவனிக்க வேண்டியவை
Investors should track the timely commissioning of the Egypt and Mexico facilities as they are critical for the next leg of growth. The shift toward high-margin aseptic packaging and recycled plastics (PCR) is a positive strategic move for long-term value creation.
⚠️இந்தத் தளம் எவ்வாறு உருவாக்கப்படுகிறது: சந்தைத் தரவுப் பக்கங்கள் NSE/BSE வெளியீடுகள் மற்றும் நிறுவனங்களின் தாக்கல்களிலிருந்து தானாகக் கணக்கிடப்படுகின்றன; செய்திக் கட்டுரைகளும் அறிவிப்புப் பகுப்பாய்வுகளும் AI உதவியுடன் எழுதப்படுகின்றன, மனித மேற்பார்வையுடன்: AI உருவாக்குவதை எங்கள் ஆசிரியர்கள் மதிப்பாய்வு செய்கின்றனர். இரண்டிலும் பிழைகள் இருக்கலாம். எந்தவொரு முதலீட்டு முடிவுக்கு முன்பும் அசல் மூலங்களில் சரிபார்க்கவும். முதலீட்டு ஆலோசனை அல்ல; Flash Finance SEBI-பதிவு பெற்றது அல்ல. நாங்கள் AI-ஐ எவ்வாறு பயன்படுத்துகிறோம்
🎁 ஆரம்பகால ஆதரவாளர்களுக்கு மட்டும் · குறுகிய கால சலுகை
எங்கள் AI பங்குச் சந்தை பகுப்பாய்வு: டெலிகிராம், வாட்ஸ்அப்பில் இலவசம்
⚡ 3500+ நிறுவனங்களை நாங்கள் உடனுக்குடன் கண்காணிக்கிறோம். NSE-யில் ஒரு நிறுவன அறிவிப்பு வெளியானதுமே, எங்கள் AI அதைப் படித்து, சுருக்கி, அதன் தாக்கத்தைச் சில நொடிகளில் உங்களுக்குச் சொல்கிறது.
இதுபோன்ற AI பகுப்பாய்வுக்குக் கட்டணத் தளங்கள் ஆண்டுக்கு ₹1,00,000-க்கும் மேல் வசூலிக்கின்றன. எங்கள் சேனல்களில் இது இலவசம்.
